Summary & Overview
Heart Transplant or Implant of Heart Assist System with MCC: Inpatient Reimbursement Overview
DRG 001 includes heart transplant and implantation of heart assist systems when a Major Complication or Comorbidity is present, encompassing the most resource-intensive cardiac surgical admissions. Correct DRG assignment matters for inpatient reimbursement because it determines Medicare payments and reflects the high costs of complex perioperative care and prolonged critical care stays.
DRG 001 Overview
DRG 001 covers heart transplant procedures and the implantation of ventricular assist devices or other heart assist systems with a Major Complication or Comorbidity (MCC). This group captures the highest-severity cardiac surgical admissions and is associated with substantial resource use, including intensive care, complex surgery, and prolonged hospitalization. It is one of the highest-paying Diagnosis-Related Groups under Medicare, reflecting the intensive services and costs required for these patients. Accurate assignment affects inpatient payment and hospital case-mix indexing.
National Payment Rates
State Payment Rates
State: Alaska1 / 49
Alaska Benchmarks
Payer rates for DRG 001 in Alaska range from $400K to $550K across observed payers, with Anthem and Blue Cross Blue Shield reported at $440K and Cigna exhibiting both the lowest reported 25th percentile ($400K) and the highest 75th percentile ($550K). The commercial average is $450K, while mean rates cluster around $440K–$490K depending on payer. This reflects notable variability driven largely by Cigna's wide percentile spread.
Key Insights for Alaska
- Anthem is the highest reported payer at $440K (tied with Blue Cross Blue Shield), while Cigna shows the widest variability with a mean of $490K but a 25th percentile of $400K and 75th of $550K, indicating inconsistency across contracts.
- The overall payer range spans from $400K (Cigna 25th percentile) to $550K (Cigna 75th percentile), a $150K spread that highlights significant dispersion despite the commercial average centering at $450K.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.